Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,261,459 papers from all fields of science
Search
Sign In
Create Free Account
ABT 526
Known as:
ABT-526
, ABT526
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
Jinyun Bai
,
Mingfeng Xia
,
+21 authors
Xin Gao
EBioMedicine
2020
Corpus ID: 220057616
Highly Cited
2006
Highly Cited
2006
Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs with Naturally Occurring Cancers
A. Rusk
,
E. McKeegan
,
F. Haviv
,
S. Majest
,
J. Henkin
,
C. Khanna
Clinical Cancer Research
2006
Corpus ID: 22574344
Purpose: The angiogenic phenotype of malignant cancers has been established as a target for cancer therapy. ABT-526 and ABT-510…
Expand
2006
2006
Cooperative Activity of Cytotoxic Chemotherapy with Antiangiogenic Thrombospondin-I Peptides, ABT-526 in Pet Dogs with Relapsed Lymphoma
A. Rusk
,
E. Cozzi
,
+6 authors
C. Khanna
Clinical Cancer Research
2006
Corpus ID: 16724825
Purpose: Thrombospondin-I (TSP-I) is a natural antiangiogenic protein that enhances apoptosis of activated endothelial cells. A…
Expand
Highly Cited
2005
Highly Cited
2005
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
F. Haviv
,
Michael F. Bradley
,
+18 authors
J. Henkin
Journal of medicinal chemistry
2005
Corpus ID: 8928550
The heptapeptide 1, NAc-Gly-Val-DIle-Thr-Arg-Ile-ArgNHEt, a structurally modified fragment derived from the second type-1 repeat…
Expand
2004
2004
A randomized placebo-controlled pre-clinical trial of the anti-angiogenic thromobspondin-mimetic peptide ABT-526 plus Lomustine chemotherapy versus Lomustine chemotherapy alone in pet dogs with…
C. Khanna
,
E. Cozzi
,
+4 authors
T. Rusk
2004
Corpus ID: 199023577
3088 Background: Thrombospondin-1 (TSP-1) is a natural antiangiogenic protein that enhances apoptosis of activated endothelial…
Expand
2004
2004
A randomized placebo-controlled pre-clinical trial of the anti-angiogenic thromobspondin-mimetic peptide ABT-526 plus Lomustine chemotherapy versus Lomustine chemotherapy alone in pet dogs with…
C. Khanna
,
E. Cozzi
,
+4 authors
T. Rusk
Journal of clinical oncology : official journal…
2004
Corpus ID: 22884696
3088 Background: Thrombospondin-1 (TSP-1) is a natural antiangiogenic protein that enhances apoptosis of activated endothelial…
Expand
Highly Cited
2003
Highly Cited
2003
Contrasting effects of VEGF gene disruption in embryonic stem cell‐derived versus oncogene‐induced tumors
A. Viloria-Petit
,
L. Miquerol
,
+8 authors
J. Rak
The EMBO journal
2003
Corpus ID: 35310972
Previous gene targeting studies have implicated an indispensable role of vascular endothelial growth factor (VEGF) in tumor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE